NCT02660216

Brief Summary

Nowadays, maxillary Le Fort I osteotomy is a safe and routinely performed procedure. The conventional approach is characterized by a vestibular incision extending from molar-to-molar, associated with a pterygomaxillary disjunction performed with a curved chisel. Adequate mobilization of the maxilla during Le Fort I osteotomy requires an effective separation of the maxillary tuberosity from the pterygoid plates of the sphenoid bone. However, as initially described by Precious (1991) and later by Hernandez-Alfaro (2013), a true pterygomaxillary osteotomy is not necessary to achieve successful disjunction. Furthermore, Hernandez-Alfaro combined his technique of pterygomaxillary disjunction, the so-called "Twist technique", to a minimally invasive protocol, performing the complete Le Fort I osteotomy through a 20 to 30 mm long horizontal vestibular incision. Although promising, the technique remains highly sensitive from a technical standpoint, and its true accuracy has not been comprehensively evaluated. The purpose of this study is to present and validate a minimally invasive approach towards Le Fort I osteotomy, using a modified pterygomaxillary (PTM) disjunction technique. The primary outcome is to evaluate the accuracy of the technique using rigid voxel-based registration of the 3D virtual treatment planning and the 4 weeks postoperative CBCT images. Secondary outcomes include the surgical time necessary to complete the procedure and the presence of intraoperative and early postoperative complications.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
20

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2014

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 1, 2014

Completed
1.2 years until next milestone

First Submitted

Initial submission to the registry

January 11, 2016

Completed
10 days until next milestone

First Posted

Study publicly available on registry

January 21, 2016

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2019

Completed
Last Updated

January 19, 2021

Status Verified

January 1, 2021

Enrollment Period

5.1 years

First QC Date

January 11, 2016

Last Update Submit

January 15, 2021

Conditions

Keywords

minimally invasivele fort I osteotomy3D virtual treatment planningaccuracy

Outcome Measures

Primary Outcomes (1)

  • accuracy of the minimally invasive approach in comparison to conventional approaches, based on 3D virtual CBCT superimposition of planning CBCT and postoperative CBCT

    at 4 weeks postoperative

Secondary Outcomes (2)

  • Surgical time necessary to complete the procedure

    perioperative

  • Intraoperative and early postoperative complications

    within 4 weeks postoperative

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

All consenting patients requiring a bimaxillary orthognathic procedure as part of their orthodontic-surgical treatment plan, and satisfying the inclusion and exclusion criteria.

You may qualify if:

  • Patients of all ages
  • Patients of all genders
  • A Le Fort I osteotomy is planned, as part of a bimaxillary orthognathic procedure
  • The surgery is planned with 3D Virtual Treatment Planning (Maxilim v. 2.3.0.3.0.)
  • The planning is transferred with 3D CAD/CAM tooth-borne splint and vertical internal bony reference landmarks
  • The maxilla is repositioned first during the surgery (maxilla first sequence)

You may not qualify if:

  • Patients not eligible according to abovementioned criteria
  • Simultaneous extraction of impacted teeth 18 and/or 28
  • Previous maxillary orthognathic surgery
  • Previous Surgical Assisted Rapid Palatal Expansion (SARPE)
  • Syndromic condition, including cleft lip and palate
  • Segmental Le Fort I osteotomy
  • Adjuvant Zygomatic osteotomy
  • Maxillary impaction higher than 3 mm
  • Maxillary advancement greater than 5 mm

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

general hospital Saint-John Bruges

Bruges, Belgium

Location

MeSH Terms

Conditions

Jaw Abnormalities

Condition Hierarchy (Ancestors)

Jaw DiseasesMusculoskeletal DiseasesMaxillofacial AbnormalitiesCraniofacial AbnormalitiesMusculoskeletal AbnormalitiesStomatognathic DiseasesStomatognathic System AbnormalitiesCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Study Officials

  • Gwen Swennen

    Division of Maxillofacial Surgery, Department of Surgery, General Hospital Saint-John Bruges, Belgium

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Maxillofacial Surgeon, MD, LDS, DMD, PhD, FEBOMFS

Study Record Dates

First Submitted

January 11, 2016

First Posted

January 21, 2016

Study Start

November 1, 2014

Primary Completion

December 1, 2019

Study Completion

December 1, 2019

Last Updated

January 19, 2021

Record last verified: 2021-01

Data Sharing

IPD Sharing
Will not share

Locations